182 related articles for article (PubMed ID: 22413833)
1. Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest.
Nagata C; Yanagida S; Okamoto A; Morikawa A; Sugimoto K; Okamoto S; Ochiai K; Tanaka T
J Obstet Gynaecol Res; 2012 Apr; 38(4):639-44. PubMed ID: 22413833
[TBL] [Abstract][Full Text] [Related]
2. Heavy uterine bleeding in women with endometriosis and adenomyosis treated with dienogest.
Chou FW; Chang WH; Wang PH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):139-140. PubMed ID: 38485301
[No Abstract] [Full Text] [Related]
3. Effective salvage of acute massive uterine bleeding using intrauterine balloon tamponade in a uterine adenomyosis patient on dienogest.
Nishino K; Hayashi K; Chaya J; Kato N; Yamamuro O
J Obstet Gynaecol Res; 2013 Mar; 39(3):738-41. PubMed ID: 23003209
[TBL] [Abstract][Full Text] [Related]
4. Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
Yanase T; Tsuneki I; Tamura M; Kurabayashi T
Gynecol Endocrinol; 2014 Nov; 30(11):804-7. PubMed ID: 25060125
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
Hirata T; Izumi G; Takamura M; Saito A; Nakazawa A; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
Gynecol Endocrinol; 2014 Oct; 30(10):726-9. PubMed ID: 24905725
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis.
Ono N; Asano R; Nagai K; Sugo Y; Nakamura T; Miyagi E
J Obstet Gynaecol Res; 2021 Apr; 47(4):1433-1440. PubMed ID: 33590656
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest.
Takagi H; Takakura M; Sasagawa T
Taiwan J Obstet Gynecol; 2023 Nov; 62(6):852-857. PubMed ID: 38008504
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
10. Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis.
Matsubara S; Kawaguchi R; Akinishi M; Nagayasu M; Iwai K; Niiro E; Yamada Y; Tanase Y; Kobayashi H
Sci Rep; 2019 Nov; 9(1):17654. PubMed ID: 31776404
[TBL] [Abstract][Full Text] [Related]
11. Use of dienogest over 53 weeks for the treatment of endometriosis.
Sugimoto K; Nagata C; Hayashi H; Yanagida S; Okamoto A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1921-6. PubMed ID: 26369271
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial.
Hassanin AI; Youssef AA; Yousef AM; Ali MK
Int J Gynaecol Obstet; 2021 Aug; 154(2):263-269. PubMed ID: 33454995
[TBL] [Abstract][Full Text] [Related]
13. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of endometriosis with dienogest].
Köhler G; Göretzlehner G; Amon I
Zentralbl Gynakol; 1987; 109(12):795-801. PubMed ID: 3630463
[TBL] [Abstract][Full Text] [Related]
15. Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration.
Fischer OM; Kaufmann-Reiche U; Moeller C; Fuhrmann U
Gynecol Obstet Invest; 2011; 72(3):145-51. PubMed ID: 21985956
[TBL] [Abstract][Full Text] [Related]
16. Long-term dienogest administration in patients with symptomatic adenomyosis.
Neriishi K; Hirata T; Fukuda S; Izumi G; Nakazawa A; Yamamoto N; Harada M; Hirota Y; Koga K; Wada-Hiraike O; Fujii T; Osuga Y
J Obstet Gynaecol Res; 2018 Aug; 44(8):1439-1444. PubMed ID: 29845696
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
Fawzy M; Mesbah Y
Arch Gynecol Obstet; 2015 Dec; 292(6):1267-71. PubMed ID: 25990480
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of parameters of liver metabolism in intermediate-term use of the gestagen dienogest in the treatment of endometriosis].
Köhler G; Lembke S; Brachmann K; Foth D; Happke S
Zentralbl Gynakol; 1989; 111(12):807-10. PubMed ID: 2763750
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of dienogest for the treatment of endometriosis.
Momoeda M; Harada T; Terakawa N; Aso T; Fukunaga M; Hagino H; Taketani Y
J Obstet Gynaecol Res; 2009 Dec; 35(6):1069-76. PubMed ID: 20025633
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
Römer T
Arch Gynecol Obstet; 2018 Oct; 298(4):747-753. PubMed ID: 30076546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
